KKR and Ampersand make takeover bid for Oxford Immunotec: Reuters

KKR and Ampersand Capital Partners have made a $400 million bid to acquire Oxford Immunotec Global Plc, reported Reuters.

KKR and Ampersand Capital Partners have made a $400 million bid to acquire Oxford Immunotec Global Plc, reported Reuters. Oxford Immunotec is a medical diagnostics company that develops tests to identify tuberculosis.

Source: Reuters